Pharma marketing & medical communications IndiaSoutheast AsiaMiddle EastAfrica

Brand Strategy: Product Launch and GTM Strategy

Pharma Launch Readiness Checklist: 40 Checks Before Launch

A 40-point pharma launch readiness checklist across evidence, compliance, brand, access, field force and supply, with when to check each.

A checklist on a clipboard beside a laptop
Fig 1. Score each check red, amber or green at six, three and one month before launch.

Most launches that stumble were not short of a good molecule. They were short of one piece of readiness that nobody owned: a claim not yet approved, a field force trained on last year's data, stock that reached the wrong cities first. This checklist gathers the 40 checks that launch teams in India review before day one, grouped by the team that owns them.

Score each check red, amber or green three times: six months, three months and one month before launch. A red in evidence or compliance at three months out is a reason to discuss the launch date, not to work weekends.

1. Evidence and Medical (8 checks)

  1. The scientific narrative is agreed and approved by medical.
  2. Core claims are mapped to the approved label and the supporting data.
  3. The publication plan covers pivotal data before launch.
  4. Evidence gaps that HCPs will raise are listed, each with an answer.
  5. A KOL advisory board has reviewed the narrative and gaps.
  6. Speakers are trained and briefed on what they may say.
  7. Medical information is ready to answer HCP queries from day one.
  8. The plan for real-world evidence after launch is drafted.

2. Regulatory and Compliance (6 checks)

  1. The approval timeline is confirmed with the regulatory team.
  2. Every promotional material has passed medical, legal and regulatory review.
  3. Materials and HCP engagements follow UCPMP 2024.
  4. Disease-awareness programmes are clearly unbranded and separate from promotion.
  5. Digital and social channels have an approved moderation and adverse-event process.
  6. Pharmacovigilance reporting is set up for the launch channels.

3. Brand and Messaging (7 checks)

  1. Target patient and prescriber segments are defined and sized.
  2. The value proposition has been tested with HCPs in the target segments.
  3. Positioning against the main competitor is agreed.
  4. The core visual aid and leave-behind are approved.
  5. Messages are adapted for each segment and channel.
  6. The launch meeting or symposium is booked and its content approved.
  7. Competitor launch activity is tracked weekly.

4. Market Access and Pricing (5 checks)

  1. The price is approved and its rationale documented.
  2. Hospital formulary and institutional listing plans are in place for key accounts.
  3. Payer and access evidence is ready for the first meetings.
  4. Patient affordability or access support is designed, if needed.
  5. Trade terms with distributors are agreed.

5. Field Force and Channels (7 checks)

  1. Representatives are trained and assessed on the clinical data.
  2. The call plan names the target HCPs for the first 90 days.
  3. Territories are aligned with where target patients are treated.
  4. Digital channels are live: HCP portal, email and WhatsApp content.
  5. Remote detailing and webinars are scheduled.
  6. The CRM tracks launch calls and HCP feedback.
  7. Field teams know how to log questions for medical affairs.

6. Supply and Operations (4 checks)

  1. Launch stock covers forecast demand plus a safety margin.
  2. Distribution reaches the priority cities first.
  3. Cold chain is validated where the product needs it.
  4. Samples and starter packs, where allowed, are ready.

7. Measurement (3 checks)

  1. Launch KPIs are agreed: prescribers reached, new prescriptions, share in segment.
  2. A weekly launch report is set up and owned.
  3. The decision points for adjusting the plan are agreed in advance.

Where Launches Usually Slip

Three gaps come up again and again. Claims are approved late, so materials reach the field after launch. Field teams are trained on the data but not on the objections HCPs will raise. And nobody owns the weekly launch report, so early warning signs are seen a quarter too late.

For the full sequence from two years before approval, read the pharma product launch roadmap. For the commercial plan behind it, see go-to-market strategy for pharma and UCPMP-compliant marketing. OneAlphaMed’s brand strategy and launch team runs launch readiness reviews for pharma brands in India and abroad.

Share on: